Cgmp production of HIV-1 envelope (ENV) bulk harvest
Active Awarded Last action
- Contract number
- HHSN27200004
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,696,523
Award facts
- Opportunity
-
- NIHAI2015035 Solicitation number
- Contract value 100% obligated
- $2,696,523.00 Current and potential, with all options
- Completion date 98% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $154,198 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $2,542,325 |
About this award
This is a $2,696,523.00 delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer, for NIAID's Preclinical Development Support program. The contract has a period of performance through December 31, 2026 and is a cost-plus-fixed-fee type. ABL, a leading contract research and manufacturing organization, provides a range of preclinical and clinical development services to support infectious disease research and product development for government agencies, academic institutions, and industry clients. This award is not set-aside. ABL holds several Indefinite Delivery Vehicles (IDVs) with NIAID, NINDS, and NCI, valued up to $149.2 million, demonstrating its broad capabilities in biopharmaceutical R&D, including manufacturing, testing, and technical expertise for vaccines, therapeutics, and diagnostics targeting infectious diseases and other health conditions.
Quick answers
Who was awarded contract HHSN27200004?
HHSN27200004 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 21, 2017.
How much is contract HHSN27200004 worth?
The government has obligated $2,696,523 on HHSN27200004.
Is contract HHSN27200004 an order under another contract?
Yes. HHSN27200004 is a delivery order under HHSN272201700010I, an indefinite delivery contract.
Was contract HHSN27200004 competed?
The extent of competition for HHSN27200004 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award